Case number 1:22-cv-01465
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 2, 2025 | 35 | NOTICE of Change of Firm Affiliation of Certain Pro Hac Vice Counsel by Lupin Ltd., Lupin Pharmaceuticals, Inc. (Phillips, John) (Entered: 01/02/2025) (3) |
| Jun 7, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burkes portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf Associated Cases: 1:22-cv-01461-CJB, 1:22-cv-01462-CJB, 1:22-cv-01465-CJB, 1:22-cv-01467-CJB(dlb) (Entered: 06/07/2023) (0) |
| Jun 7, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf Associated Cases: 1:22-cv-01461-CJB, 1:22-cv-01462-CJB, 1:22-cv-01465-CJB, 1:22-cv-01467-CJB(dlb) (Entered: 06/07/2023) (0) |
| Jun 6, 2023 | 34 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc.. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Colm F. Connolly on 6/6/2023. (nmf) (Entered: 06/06/2023) (1) |
| May 23, 2023 | 33 | NOTICE OF SERVICE of 1) Plaintiffs' First Set of Requests to Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. for the Production of Documents and Things and 2) Plaintiffs' First Set of Interrogatories to Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc. filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 05/23/2023) (2) |
| May 19, 2023 | N/A | Case associated with lead case: Create association to 1:22-cv-01461-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-1461-CFC ONLY. (nmf) (Entered: 05/19/2023) (0) |
| May 19, 2023 | 32 | SCHEDULING & CONSOLIDATION ORDER: CIVIL ACTION NO. 22-1461-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CASE ONLY. Joinder of Parties due by 3/28/2024. Amended Pleadings due by 3/28/2024. Fact Discovery completed by 6/27/2024. Expert Discovery due by 1/16/2025. Joint Claim Construction Brief due by 3/7/2024. A Markman Hearing is set for 5/1/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 3/5/2025. A Final Pretrial Conference is set for 3/26/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/7/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/18/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 05/19/2023) (30) |
| May 15, 2023 | 31 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Exhibit A) (4) |
| May 15, 2023 | 31 | PROPOSED ORDER // [Proposed] Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A)(Stover, Chad) (Entered: 05/15/2023) (Main Document) (26) |
| May 9, 2023 | 30 | Official Transcript of In-Person Scheduling Conference held on May 8, 2023 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: Bonnie_Archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/30/2023. Redacted Transcript Deadline set for 6/9/2023. Release of Transcript Restriction set for 8/7/2023. (nmf) (Entered: 05/09/2023) (0) |
| May 8, 2023 | N/A | Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 5/8/2023. (Court Reporter Bonnie Archer.) Counsel shall submit a revised proposed scheduling order to the Court on or before May 15, 2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 05/08/2023) (0) |
| Apr 27, 2023 | N/A | ORAL ORDER Setting Scheduling Conference:( An In-Person Scheduling Conference is set for 5/8/2023 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/27/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 04/27/2023) (0) |
| Apr 18, 2023 | 29 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Letter regarding Proposed Scheduling Order) (2) |
| Apr 18, 2023 | 29 | PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Letter regarding Proposed Scheduling Order)(Stover, Chad) (Entered: 04/18/2023) (Main Document) (30) |
| Apr 10, 2023 | N/A | SO ORDERED, re (34 in 1:22-cv-01467-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (28 in 1:22-cv-01465-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01462-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01461-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Signed by Judge Colm F. Connolly on 4/10/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 04/10/2023) (0) |
| Apr 7, 2023 | 28 | STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 04/07/2023) (3) |
| Feb 17, 2023 | 27 | ANSWER to 17 Answer to Complaint, Counterclaim by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) (Entered: 02/17/2023) (30) |
| Feb 10, 2023 | 26 | Letter to The Honorable Colm F. Connolly from Chad S.C. Stover regarding coordinated discovery and Markman proceedings - re (14 in 1:22-cv-01462-CFC, 14 in 1:22-cv-01462-CFC, 22 in 1:22-cv-01465-CFC, 22 in 1:22-cv-01465-CFC, 14 in 1:22-cv-01461-CFC, 14 in 1:22-cv-01461-CFC, 18 in 1:22-cv-01467-CFC, 18 in 1:22-cv-01467-CFC) Order,,, Set Deadlines,,. (Stover, Chad) (Entered: 02/10/2023) (2) |
| Jan 25, 2023 | 25 | SO ORDERED, re 24 STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Answer Deadlines: Amicus Therapeutics US, LLC answer due 2/17/2023; Amicus Therapeutics, Inc. answer due 2/17/2023. Signed by Judge Colm F. Connolly on 1/25/2023. (kmd) (Entered: 01/25/2023) (3) |
| Jan 24, 2023 | 24 | STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 01/24/2023) (3) |
| Jan 19, 2023 | 23 | MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) Modified on 1/19/2023 (kmd). (Entered: 01/19/2023) (4) |
| Jan 19, 2023 | N/A | SO ORDERED, re (23 in 1:22-cv-01465-CFC) (15 in 1:22-cv-01461-CFC) (19 in 1:22-cv-01467-CFC) (15 in 1:22-cv-01462-CFC) MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 1/19/2023. Associated Cases: 1:22-cv-01465-CFC, 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01467-CFC(kmd) (Entered: 01/19/2023) (0) |
| Jan 18, 2023 | N/A | Pro Hac Vice Attorney Joshua E. Ney for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mkr) (Entered: 01/18/2023) (0) |
| Jan 17, 2023 | N/A | Pro Hac Vice Attorney Lauren Baker for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) (Entered: 01/17/2023) (0) |
| Jan 12, 2023 | 22 | ORDER, IT IS ORDERED that, on or before February 10, 2023, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to these cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/10/2023.) Signed by Judge Colm F. Connolly on 1/12/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf) (Entered: 01/12/2023) (3) |
| Jan 10, 2023 | N/A | Pro Hac Vice Attorney Christina M. Baugh for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) (Entered: 01/10/2023) (0) |
| Jan 10, 2023 | N/A | Pro Hac Vice Attorneys John W. Cox, Joshua M. Kalb, Mark C. Nelson, Anna Whitacre for Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(twk) (Entered: 01/10/2023) (0) |
| Jan 6, 2023 | 17 | ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) (Entered: 01/06/2023) (30) |
| Jan 6, 2023 | 18 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Ltd.. (Phillips, John) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 19 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 01/06/2023) (2) |
| Jan 6, 2023 | 20 | NOTICE of Appearance by David A. Bilson on behalf of Lupin Ltd., Lupin Pharmaceuticals, Inc. (Bilson, David) (Entered: 01/06/2023) (1) |
| Jan 6, 2023 | 21 | NOTICE of Withdrawal of Megan C. Haney by Lupin Ltd., Lupin Pharmaceuticals, Inc. (Haney, Megan) (Entered: 01/06/2023) (1) |
| Dec 7, 2022 | N/A | SO ORDERED, re (11 in 1:22-cv-01462-CFC) (16 in 1:22-cv-01465-CFC) (11 in 1:22-cv-01461-CFC) (12 in 1:22-cv-01467-CFC) MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 12/7/2022. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(kmd) (Entered: 12/07/2022) (0) |
| Dec 7, 2022 | 16 | MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/07/2022) (11) |
| Dec 7, 2022 | N/A | Pro Hac Vice Attorney Keith D. Parr, Nina Vachhani, Amy Lange Miller, Jacob C. Britz, and Jonathan B. Turpin for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/07/2022) (0) |
| Dec 6, 2022 | 15 | AFFIDAVIT of Service for Complaint served on counsel for Lupin Ltd. on 11/8/2022, filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/06/2022) (2) |
| Dec 6, 2022 | N/A | SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 12/6/2022. (kmd) (Entered: 12/06/2022) (0) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Main Document) (2) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Certification of Jacob C. Britz) (1) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Certification of Amy Lange Miller) (1) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Certification of Jonathan B. Turpin) (1) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Certification of Nina Vachhani) (1) |
| Dec 6, 2022 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of Keith D. Parr, # 2 Certification of Nina Vachhani, # 3 Certification of Jonathan B. Turpin, # 4 Certification of Amy Lange Miller, # 5 Certification of Jacob C. Britz)(Haney, Megan) (Entered: 12/06/2022) (Certification of Keith D. Parr) (1) |
| Dec 2, 2022 | 13 | SO ORDERED, re 12 Stipulation to Amend Caption, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Signed by Judge Colm F. Connolly on 12/2/2022. (kmd) (Entered: 12/02/2022) (3) |
| Dec 1, 2022 | 12 | Joint STIPULATION and [Proposed] Order to Amend Caption by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) (Entered: 12/01/2022) (3) |
| Dec 1, 2022 | 11 | NOTICE of Voluntary Dismissal by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. as to Springcare USA LLC d/b/a Spring Bio Solution (Stover, Chad) (Entered: 12/01/2022) (3) |
| Nov 29, 2022 | N/A | SO ORDERED, re 9 STIPULATION TO EXTEND TIME move, answer, plead or otherwise respond to the Complaint to January 6, 2023, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 1/6/2023; Lupin Pharmaceuticals, Inc. answer due 1/6/2023. Ordered by Judge Colm F. Connolly on 11/29/2022. (kmd) (Entered: 11/29/2022) (0) |
| Nov 29, 2022 | 10 | NOTICE of Appearance by Megan C. Haney on behalf of Lupin Ltd., Lupin Pharmaceuticals, Inc. (Haney, Megan) (Entered: 11/29/2022) (2) |
| Nov 28, 2022 | 9 | STIPULATION TO EXTEND TIME move, answer, plead or otherwise respond to the Complaint to January 6, 2023 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 11/28/2022) (3) |
| Nov 9, 2022 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC (rjb) (Entered: 11/09/2022) (0) |
| Nov 8, 2022 | 8 | SUMMONS Returned Executed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..Lupin Pharmaceuticals, Inc. served on 11/8/2022, answer due 11/29/2022. (Stover, Chad) (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics, Inc.. (lam) Modified on 11/8/2022 (lam). (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amicus Therapeutics, Inc. for Amicus Therapeutics US, LLC filed by Amicus Therapeutics US, LLC. (lam) (Main Document 5 replaced on 11/8/2022) (lam). (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attachment. (lam) (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 1 | COMPLAINT For Patent Infringement filed against Lupin Ltd., Lupin Pharmaceuticals, Inc., Springcare USA LLC ( Filing fee $ 402, receipt number ADEDC-4000504.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A-N, # 2 Exhibit O-W, # 3 Civil Cover Sheet)(lam) (Entered: 11/08/2022) (Exhibit A-N) (30) |
| Nov 7, 2022 | 1 | COMPLAINT For Patent Infringement filed against Lupin Ltd., Lupin Pharmaceuticals, Inc., Springcare USA LLC ( Filing fee $ 402, receipt number ADEDC-4000504.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A-N, # 2 Exhibit O-W, # 3 Civil Cover Sheet)(lam) (Entered: 11/08/2022) (Exhibit O-W) (30) |
| Nov 7, 2022 | 1 | COMPLAINT For Patent Infringement filed against Lupin Ltd., Lupin Pharmaceuticals, Inc., Springcare USA LLC ( Filing fee $ 402, receipt number ADEDC-4000504.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A-N, # 2 Exhibit O-W, # 3 Civil Cover Sheet)(lam) (Entered: 11/08/2022) (Civil Cover Sheet) (2) |
| Nov 7, 2022 | 7 | Summons Issued as to Lupin Ltd. on 11/7/2022; Lupin Pharmaceuticals, Inc. on 11/7/2022; Springcare USA LLC on 11/7/2022. (Attachments: # 1 Summons Forms - Unsigned Lupin Pharmaceuticals, Inc., # 2 Summons Forms - Unsigned Springcare USA LLC d/b/a Spring Bio Solution)(lam) (Entered: 11/08/2022) (Main Document) (2) |
| Nov 7, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 5, 2022. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/10/2026. (lam) (Entered: 11/08/2022) (3) |
| Nov 7, 2022 | 7 | Summons Issued as to Lupin Ltd. on 11/7/2022; Lupin Pharmaceuticals, Inc. on 11/7/2022; Springcare USA LLC on 11/7/2022. (Attachments: # 1 Summons Forms - Unsigned Lupin Pharmaceuticals, Inc., # 2 Summons Forms - Unsigned Springcare USA LLC d/b/a Spring Bio Solution)(lam) (Entered: 11/08/2022) (Summons Forms - Unsigned Lupin Pharmaceuticals, Inc.) (2) |
| Nov 7, 2022 | 7 | Summons Issued as to Lupin Ltd. on 11/7/2022; Lupin Pharmaceuticals, Inc. on 11/7/2022; Springcare USA LLC on 11/7/2022. (Attachments: # 1 Summons Forms - Unsigned Lupin Pharmaceuticals, Inc., # 2 Summons Forms - Unsigned Springcare USA LLC d/b/a Spring Bio Solution)(lam) (Entered: 11/08/2022) (Summons Forms - Unsigned Springcare USA LLC d/b/a Spring Bio Solution) (2) |
| Nov 7, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) (Entered: 11/08/2022) (3) |
| Nov 7, 2022 | 1 | COMPLAINT For Patent Infringement filed against Lupin Ltd., Lupin Pharmaceuticals, Inc., Springcare USA LLC ( Filing fee $ 402, receipt number ADEDC-4000504.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: # 1 Exhibit A-N, # 2 Exhibit O-W, # 3 Civil Cover Sheet)(lam) (Entered: 11/08/2022) (Main Document) (30) |
